Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York

Children's Hospital of Pittsburgh, Pittsburgh

Winship Cancer Institute of Emory University, Atlanta

Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham

St. Jude Children's Research Hospital, Memphis

Masonic Cancer Center at University of Minnesota, Minneapolis

Children's Memorial Hospital - Chicago, Chicago

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas

Children's Hospital of Orange County, Orange

Children's Hospital and Regional Medical Center - Seattle, Seattle

Children's National Medical Center, Washington D.C.

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

C.S. Mott Children's Hospital at University of Michigan Medical Center, Ann Arbor

Cincinnati Children's Hospital Medical Center, Cincinnati

Knight Cancer Institute at Oregon Health and Science University, Portland

Children's Hospital of Philadelphia, Philadelphia

Vanderbilt-Ingram Cancer Center, Nashville

Baylor University Medical Center - Houston, Houston